EUVIMEDEUVIMED entdecken
Crossref

Low Molecular Weight Acids and Organic Anion Transporting Polypeptide (OATP1B)-Mediated Hepatic Clearance: In Vitro and In Vivo Evaluation Using Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (Dustats)

Yi-An Bi, Samantha Jordan, Amanda King-Ahmad, Mark A West, Emi Yamaguchi, Sangwoo Ryu, Sumathy Mathialagan, David A Tess, Manthena V S Varma iD

Drug Metabolism and Disposition · 2024

DOI: 10.1124/dmd.123.001630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2024. Verfasst von Yi-An Bi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc., United States. Hauptthemen laut MEDLINE: Prolyl-Hydroxylase Inhibitors, Liver-Specific Organic Anion Transporter 1, Liver. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prolyl-Hydroxylase InhibitorsLiver-Specific Organic Anion Transporter 1LiverHumansAnimalsHEK293 CellsHepatocytesMaleMacaca fascicularisMolecular WeightBiological TransportGlycineMetabolic Clearance RateRifampin

Stichwörter der Autor:innen

Organic anion uptake / efflux (OATs, OATPs)active transportanimal/nonclinical/preclinicaldrug clearancepharmacokinetic

Substanzen

Prolyl-Hydroxylase InhibitorsLiver-Specific Organic Anion Transporter 1SLCO1B1 protein, humanGlycineRifampin

Autor:innen und Institutionen

  • Pfizer Inc., United States.
  • Medicine Design, Pfizer Inc, United States.
  • Pfizer Inc, United States.
  • Pharmacokinetics, Pharmacodynamics, and Metabolism, Medicine Design, Pfizer Inc, United States.
  • Medicine Design, Pfizer Inc., United States.
  • Pharmacokinetics Dynamics and Metabolism, Pfizer Inc, United States manthena.v.varma@pfizer.com.

ORCID-Profile: Manthena V S Varma

Zitieren

APA

Bi, Y. A., Jordan, S., King-Ahmad, A., West, M. A., Yamaguchi, E., Ryu, S., Mathialagan, S., Tess, D. A., & Varma, M. V. S. (2024). Low Molecular Weight Acids and Organic Anion Transporting Polypeptide (OATP1B)-Mediated Hepatic Clearance: In Vitro and In Vivo Evaluation Using Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (Dustats). Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001630

Vancouver

Bi YA, Jordan S, King-Ahmad A, West MA, Yamaguchi E, Ryu S, et al. Low Molecular Weight Acids and Organic Anion Transporting Polypeptide (OATP1B)-Mediated Hepatic Clearance: In Vitro and In Vivo Evaluation Using Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (Dustats). Drug Metabolism and Disposition. 2024. doi:10.1124/dmd.123.001630

BibTeX
@article{Bi2024,
  author = {Bi, Yi-An and Jordan, Samantha and King-Ahmad, Amanda and West, Mark A and Yamaguchi, Emi and Ryu, Sangwoo and Mathialagan, Sumathy and Tess, David A and Varma, Manthena V S},
  title = {Low Molecular Weight Acids and Organic Anion Transporting Polypeptide (OATP1B)-Mediated Hepatic Clearance: In Vitro and In Vivo Evaluation Using Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (Dustats)},
  journal = {Drug Metabolism and Disposition},
  year = {2024},
  doi = {10.1124/dmd.123.001630}
}
Kostenlos starten →